trial

Anti-inflammatories and Adolescent Schizophrenia

NCTId NCT04020588
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Unknown
Enrollment 90 (estimated)
Sponsored by Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico
Primary completion 2020-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Unknown
Enrollment
90 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2019-02-25
Primary completion
2020-06
Eligibility
ALL · 12 Years · 17 Years

Interventions & indications

Drugs
Celecoxib 200mgMinocycline

Sponsors

Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, MexicoLead Sponsor

Sites

1 total
Mexico City, Mexico

Facts & assertions

4 sourced
Enrollment
90
Phase
PHASE4
Primary Completion Date
2020-06
Status
UNKNOWN
relationships
The graph out of here
drug
Celecoxib 200mg
drug
Minocycline
drug
lead_sponsor
Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico
company
indication
Schizophrenia
indication
Schizophrenia
indication
Inflammation
indication